112 related articles for article (PubMed ID: 7150335)
1. Dopamine receptors in rat brain regions. Optimal conditions for 3H-agonist binding, pH dependency and lack of inhibition by ascorbic acid.
Bacopoulos NG
Biochem Pharmacol; 1982 Oct; 31(19):3085-91. PubMed ID: 7150335
[TBL] [Abstract][Full Text] [Related]
2. Optimal conditions for [3H]apomorphine binding and anomalous equilibrium binding of [3H]apomorphine and [3H]spiperone to rat striatal membranes: involvement of surface phenomena versus multiple binding sites.
Leysen JE; Gommeren W
J Neurochem; 1981 Jan; 36(1):201-19. PubMed ID: 7463046
[TBL] [Abstract][Full Text] [Related]
3. Properties of dopamine agonist and antagonist binding sites in mammalian retina.
Makman MH; Dvorkin B; Horowitz SG; Thal LJ
Brain Res; 1980 Aug; 194(2):403-18. PubMed ID: 6770965
[TBL] [Abstract][Full Text] [Related]
4. Computer imaging and analysis of dopamine (D2) and serotonin (S2) binding sites in rat basal ganglia or neocortex labeled by [3H]spiroperidol.
Altar CA; Kim H; Marshall JF
J Pharmacol Exp Ther; 1985 May; 233(2):527-38. PubMed ID: 3889277
[TBL] [Abstract][Full Text] [Related]
5. Effects of proteolytic enzymes and monovalent ions demonstrate protease-sensitive and protease-insensitive stereospecific binding sites on dopaminergic receptors in rat striatum.
Leysen JE; Van Gompel P
Biochem Pharmacol; 1982 Apr; 31(7):1343-55. PubMed ID: 7046754
[TBL] [Abstract][Full Text] [Related]
6. Reversible decrease in dopaminergic 3H-agonist binding after 6-hydroxydopamine and irreversible decrease after kainic acid.
Schweitzer BI; Bacopoulos NG
Life Sci; 1983 Jan; 32(5):531-40. PubMed ID: 6296593
[TBL] [Abstract][Full Text] [Related]
7. Dopamine receptors on intact anterior pituitary cells in culture: functional association with the inhibition of prolactin and thyrotropin.
Foord SM; Peters JR; Dieguez C; Scanlon MF; Hall R
Endocrinology; 1983 May; 112(5):1567-77. PubMed ID: 6832061
[TBL] [Abstract][Full Text] [Related]
8. Guanyl nucleotide interactions with dopaminergic binding sites labeled by [3H]spiroperidol in human caudate and putamen: guanyl nucleotides enhance ascorbate-induced lipid peroxidation and cause an apparent loss of high affinity binding sites.
Andorn AC; Bacon BR; Nguyen-Hunh AT; Parlato SJ; Stitts JA
Mol Pharmacol; 1988 Feb; 33(2):155-62. PubMed ID: 3340080
[TBL] [Abstract][Full Text] [Related]
9. Multiple receptors for brain dopamine.
Titeler M; Weinreich P; Sinclair D; Seeman P
Proc Natl Acad Sci U S A; 1978 Mar; 75(3):1153-6. PubMed ID: 418405
[TBL] [Abstract][Full Text] [Related]
10. Dopamine receptor binding in inbred mice: strain differences in mesolimbic and nigrostriatal dopamine binding sites.
Boehme RE; Ciaranello RD
Proc Natl Acad Sci U S A; 1981 May; 78(5):3255-9. PubMed ID: 6166945
[TBL] [Abstract][Full Text] [Related]
11. Effects of pH and ascorbic acid on 3H-spiperone and 3H-dihydroalprenolol binding in rat forebrain homogenates.
Bruinink A; Lichtensteiger W
J Recept Res; 1984; 4(1-6):127-39. PubMed ID: 6527352
[TBL] [Abstract][Full Text] [Related]
12. Species variation in dopamine receptor binding.
Creese I; Stewart K; Snyder SH
Eur J Pharmacol; 1979 Nov; 60(1):55-66. PubMed ID: 520417
[TBL] [Abstract][Full Text] [Related]
13. Thermodynamic differences between agonist and antagonist interactions with binding sites for [3H]spiroperidol in rat striatum.
Zahniser NR; Molinoff PB
Mol Pharmacol; 1983 Mar; 23(2):303-9. PubMed ID: 6835199
[TBL] [Abstract][Full Text] [Related]
14. Interactions of dopaminergic agonists and antagonists with dopaminergic D3 binding sites in rat striatum. Evidence that [3H]dopamine can label a high affinity agonist-binding state of the D1 dopamine receptor.
Leff SE; Creese I
Mol Pharmacol; 1985 Feb; 27(2):184-92. PubMed ID: 3969067
[TBL] [Abstract][Full Text] [Related]
15. Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase.
Makman MH; Dvorkin B
Brain Res; 1986 Dec; 387(3):261-70. PubMed ID: 2950967
[TBL] [Abstract][Full Text] [Related]
16. [3H]dopamine labeling of D3 dopaminergic sites in human, rat, and calf brain.
List SJ; Seeman P
J Neurochem; 1982 Nov; 39(5):1363-73. PubMed ID: 7119802
[TBL] [Abstract][Full Text] [Related]
17. [3H]-quinelorane binds to D2 and D3 dopamine receptors in the rat brain.
Gackenheimer SL; Schaus JM; Gehlert DR
J Pharmacol Exp Ther; 1995 Sep; 274(3):1558-65. PubMed ID: 7562534
[TBL] [Abstract][Full Text] [Related]
18. Characterization of [3H]quinpirole binding to D2-like dopamine receptors in rat brain.
Levant B; Grigoriadis DE; DeSouza EB
J Pharmacol Exp Ther; 1992 Sep; 262(3):929-35. PubMed ID: 1356154
[TBL] [Abstract][Full Text] [Related]
19. Differential inhibitory effects of ascorbic acid on the binding of dopamine agonists and antagonists to neostriatal membrane preparations: correlations with behavioral effects.
Heikkila RE; Cabbat FS; Manzino L
Res Commun Chem Pathol Pharmacol; 1981 Dec; 34(3):409-21. PubMed ID: 7323442
[TBL] [Abstract][Full Text] [Related]
20. Heat treatment mimics guanosine-5'-triphosphate effects on dopaminergic 3H-ligand binding to bovine caudate membranes.
Hamblin MW; Creese I
Mol Pharmacol; 1982 Jan; 21(1):52-6. PubMed ID: 7132962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
